Literature DB >> 3299708

erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation.

V N Rao, T S Papas, E S Reddy.   

Abstract

The avian acute leukemia virus E26 induces a mixed erythroid-myeloid leukemia in chickens and carries two distinct oncogenes, v-myb and v-ets. Recently, a novel gene named erg, closely related to the v-ets oncogene, was identified in human COLO 320 cells and the nucleotide sequence of its approximately 5.0-kilobase transcript, erg 1 was determined. In the present study, the nucleotide sequence of the alternatively spliced transcript, erg 2, was found to differ from erg 1 by a splicing event that causes a coding frameshift near the amino terminus, resulting in an additional 99-amino acid insertion at the amino-terminus. Expression of complementary DNAs for the two transcripts in vitro resulted in synthesis of polypeptides of approximately 41 and 52 kilodaltons, suggesting the use of alternative translation initiation codons in the case of erg proteins. The erg gene was localized by somatic cell genetic analysis to human chromosome 21. It is proposed that alternative sites of splicing and polyadenylation, together with alternative sites of translation initiation, allow the synthesis of two related polypeptides from a single erg gene transcriptional unit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299708     DOI: 10.1126/science.3299708

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  65 in total

1.  Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).

Authors:  H Ichikawa; K Shimizu; R Katsu; M Ohki
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

Authors:  Wendell S Fortson; Shubhalaxmi Kayarthodi; Yasuo Fujimura; Huali Xu; Roland Matthews; William E Grizzle; Veena N Rao; Ganapathy K Bhat; E Shyam P Reddy
Journal:  Int J Oncol       Date:  2011-04-21       Impact factor: 5.650

Review 3.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

4.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

Authors:  N K Bhat; C B Thompson; T Lindsten; C H June; S Fujiwara; S Koizumi; R J Fisher; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Neurogenic potential of Ewing's sarcoma cells.

Authors:  T Sugimoto; A Umezawa; J Hata
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

7.  Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro.

Authors:  K E Boulukos; P Pognonec; B Rabault; A Begue; J Ghysdael
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

Review 8.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

9.  Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein.

Authors:  D B Woods; J Ghysdael; M J Owen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

10.  Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody.

Authors:  Ahmed A Mohamed; Shyh-Han Tan; Natallia Mikhalkevich; Sathibalan Ponniah; Valeri Vasioukhin; Charles J Bieberich; Isabell A Sesterhenn; Albert Dobi; Shiv Srivastava; Taduru L Sreenath
Journal:  J Cancer       Date:  2010-10-25       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.